Conagra Brands, Inc. · CAG · FY2025 Q2 · Calendar Q4 2024
Conagra sees volume recovery, but inflation and FX pressure margins
The quarter showed evidence of volume and share recovery in frozen and snacks, but the investment case remains balanced by inflation, foreign-exchange and price-mix pressures. Management is relying on brand investment, portfolio reshaping, cash generation and debt reduction to support the longer-term plan.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about CAG FY2025 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Management reported volume recovery and market-share gains, but said inflation relief is expected later and that a stronger dollar will weigh on the second half. Guidance was revised, while debt reduction and portfolio reshaping remained priorities.
Guidance delta
Management revised guidance to flat to -1.5% organic net sales, adjusted operating margin of about 14.8%, and EPS of $2.45-$2.50.
Key takeaways
- Frozen meals and snacks drove volume recovery and market-share gains.
- Management said higher inflation and a stronger dollar will pressure second-half profitability.
- Debt reduction remains a priority, with leverage expected to move toward 3.0x by fiscal 2026.
- Brand building and targeted promotions remain central to the operating plan.
Management priorities
- Invest in brands and targeted promotions.
- Focus the portfolio on frozen and snack categories.
- Continue debt reduction toward a 3.0x net leverage target by fiscal 2026.
- Use free cash flow to support strategic initiatives.
Follow CAG with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 7, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Overweight | Overweight | Maintain | Oct 2, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Oct 1, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Oct 1, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | Sep 18, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 16, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 16, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 5, 2026 |
| Bernstein | Underperform | Market Perform | Downgrade | Jun 3, 2026 |
| Wells Fargo | Underweight | Underweight | Maintain | May 18, 2026 |
| Stifel | Hold | Hold | Maintain | Apr 21, 2026 |
| BNP Paribas | Neutral | Outperform | Downgrade | Apr 9, 2026 |
| Goldman Sachs | Sell | Sell | Maintain | Apr 2, 2026 |
| TD Cowen | Hold | Hold | Maintain | Dec 22, 2025 |
| B of A Securities | Underperform | Underperform | Maintain | Dec 22, 2025 |
| Jefferies | Hold | Hold | Maintain | Dec 12, 2025 |
| Citigroup | Neutral | Neutral | Maintain | Jun 28, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Mar 31, 2023 |
| SunTrust Robinson Humphrey | Hold | Buy | Downgrade | May 11, 2020 |
| CFRA | Strong Buy | Buy | Upgrade | Mar 12, 2020 |
| Stifel Nicolaus | Buy | Hold | Upgrade | Oct 30, 2017 |
| Bank of America | Buy | Neutral | Upgrade | Feb 12, 2016 |
| Keybanc | Hold | Buy | Downgrade | Jun 18, 2014 |
| S&P Capital IQ | Buy | Strong Buy | Downgrade | Dec 19, 2013 |
| Edward Jones | Buy | Hold | Upgrade | Dec 13, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $13.25. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Evercore ISI | Analyst unavailable | $14 | $13.46 | +5.7% | Oct 1, 2026 |
| Evercore ISI | Analyst unavailable | $13 | $14.16 | -1.9% | Sep 29, 2026 |
| Deutsche Bank | Steve Powers | $13 | $15.12 | -1.9% | Sep 18, 2026 |
| Evercore ISI | Analyst unavailable | $12.5 | $14.61 | -5.7% | Sep 14, 2026 |
| UBS | Peter Grom | $14 | $14.44 | +5.7% | Jul 16, 2026 |
| RBC Capital | Analyst unavailable | $14 | $14.28 | +5.7% | Jul 16, 2026 |
| Barclays | Analyst unavailable | $16 | $14.04 | +20.8% | Jul 8, 2026 |
| RBC Capital | Analyst unavailable | $16 | $13.89 | +20.8% | Jun 25, 2026 |
| Deutsche Bank | Steve Powers | $12 | $13.16 | -9.4% | Jun 18, 2026 |
| Morgan Stanley | Megan Alexander Clapp | $13 | $12.66 | -1.9% | Jun 5, 2026 |
| Coker Palmer | Thomas Palmer | $14 | $12.66 | +5.7% | Jun 5, 2026 |
| Bernstein | Analyst unavailable | $12 | $12.86 | -9.4% | Jun 3, 2026 |
| UBS | Peter Grom | $13 | $12.92 | -1.9% | Jun 2, 2026 |
| Morgan Stanley | Megan Alexander Clapp | $15 | $14.53 | +13.2% | Apr 23, 2026 |
| Stifel Nicolaus | Analyst unavailable | $15 | $14.84 | +13.2% | Apr 21, 2026 |
| BNP Paribas | Analyst unavailable | $16 | $15.55 | +20.8% | Apr 9, 2026 |
| Wells Fargo | Chris Carey | $15 | $16.98 | +13.2% | Mar 12, 2026 |
| UBS | Analyst unavailable | $20 | $19.52 | +50.9% | Feb 13, 2026 |
| Morgan Stanley | Megan Alexander Clapp | $18 | $17.38 | +35.8% | Jan 16, 2026 |
| Wells Fargo | Analyst unavailable | $18 | $17.05 | +35.8% | Jan 5, 2026 |
| Bernstein | Alexia Howard | $18 | $17.48 | +35.8% | Dec 29, 2025 |
| UBS | Peter Grom | $18 | $17.26 | +35.8% | Dec 23, 2025 |
| Deutsche Bank | Steve Powers | $18 | $17.3 | +35.8% | Dec 22, 2025 |
| Morgan Stanley | Analyst unavailable | $19 | $17.36 | +43.4% | Dec 22, 2025 |
| Evercore ISI | David Palmer | $22 | $17.36 | +66.0% | Dec 22, 2025 |
| RBC Capital | Analyst unavailable | $20 | $17.35 | +50.9% | Dec 22, 2025 |
| RBC Capital | Nik Modi | $22 | $17.74 | +66.0% | Dec 17, 2025 |
| Wells Fargo | Analyst unavailable | $19 | $17.83 | +43.4% | Dec 12, 2025 |
| Jefferies | Analyst unavailable | $18 | $17.6 | +35.8% | Dec 11, 2025 |
| Stifel Nicolaus | Analyst unavailable | $19 | $17.44 | +43.4% | Dec 11, 2025 |
| Goldman Sachs | Analyst unavailable | $16 | $17.52 | +20.8% | Nov 25, 2025 |
| Wells Fargo | Chris Carey | $20 | $19.3 | +50.9% | Oct 2, 2025 |
| Morgan Stanley | Megan Alexander Clapp | $20 | $19.4 | +50.9% | Jul 11, 2025 |
| Bernstein | Alexia Howard | $21 | $19.4 | +58.5% | Jul 11, 2025 |
| Morgan Stanley | Megan Alexander | $22 | $20.52 | +66.0% | Jul 7, 2025 |
| Evercore ISI | David Palmer | $26 | $20.99 | +96.2% | Jul 7, 2025 |
| Jefferies | Rob Dickerson | $30 | $32.31 | +126.4% | Sep 24, 2024 |
| Coker Palmer | Thomas Palmer | $33 | $32.31 | +149.1% | Sep 24, 2024 |
| Goldman Sachs | Leah Jordan | $36 | $29.82 | +171.7% | Aug 12, 2024 |
| Stifel Nicolaus | Matthew Smith | $30 | $28.38 | +126.4% | Jul 12, 2024 |
| Barclays | Andrew Lazar | $34 | $31.09 | +156.6% | Apr 8, 2024 |
| Wells Fargo | Chris Carey | $32 | $30.64 | +141.5% | Apr 5, 2024 |
| Stifel Nicolaus | Matthew Smith | $32 | $30.64 | +141.5% | Apr 5, 2024 |
| Coker Palmer | Thomas Palmer | $32 | $30.64 | +141.5% | Apr 5, 2024 |
| Morgan Stanley | Pamela Kaufman | $32 | $30.64 | +141.5% | Apr 5, 2024 |
| CFRA | Arun Sundaram | $34 | $30.64 | +156.6% | Apr 4, 2024 |
| Evercore ISI | David Palmer | $32 | $29.06 | +141.5% | Apr 4, 2024 |
| RBC Capital | Nik Modi | $29 | $29.58 | +118.9% | Apr 1, 2024 |
| Stifel Nicolaus | Matthew Smith | $43 | $35.96 | +224.5% | May 19, 2023 |
| Deutsche Bank | Steve Powers | $35 | $35.52 | +164.2% | Mar 20, 2023 |
| RBC Capital | Conagra Brands | $38 | $40.58 | +186.8% | Jan 6, 2023 |
| J.P. Morgan | Analyst unavailable | $43 | $41 | +224.5% | Jan 6, 2023 |
| Morgan Stanley | Analyst unavailable | $48 | $40.5 | +262.3% | Jan 6, 2023 |
| UBS | Analyst unavailable | $45 | $40.66 | +239.6% | Jan 6, 2023 |
| Credit Suisse | Analyst unavailable | $40 | $39.97 | +201.9% | Jan 6, 2023 |
| Evercore ISI | Analyst unavailable | $42 | $38.77 | +217.0% | Dec 29, 2022 |
| Morgan Stanley | Pamela Kaufman | $45 | $38.49 | +239.6% | Dec 20, 2022 |
| Deutsche Bank | Steve Powers | $34 | $38.25 | +156.6% | Dec 6, 2022 |
| UBS | Cody Ross | $41 | $35.81 | +209.4% | Nov 18, 2022 |
| BNP Paribas | Analyst unavailable | $42 | $33.91 | +217.0% | Nov 15, 2022 |
| Morgan Stanley | Pamela Kaufman | $34 | $33.83 | +156.6% | Jul 15, 2022 |
| Morgan Stanley | Pamela Kaufman | $36 | $35.11 | +171.7% | Jan 14, 2022 |
| Citigroup | Wendy Nicholson | $37 | $32.96 | +179.2% | Jul 14, 2021 |
| Stifel Nicolaus | Christopher Growe | $35 | $32.96 | +164.2% | Jul 14, 2021 |
| Barclays | Andrew Lazar | $39 | $32.96 | +194.3% | Jul 14, 2021 |
Track every rating change on CAG the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationConagra Brands, Inc., a prominent manufacturer of packaged food products, conducts its business across North America through its various subsidiary companies. The firm organizes its extensive operations into four distinct segments: Grocery & Snacks, Refrigerated & Frozen, International, and Foodservice. The Grocery & Snacks division primarily distributes non-perishable food items through various retail channels within the United States. In contrast, the Refrigerated & Frozen segment focuses on supplying temperature-sensitive food products to comparable U.S. retail outlets.…
Historical context
All CAG earningsConsumer Defensive peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| LW Lamb Weston Holdings, Inc. | FY2027 Q1 · Calendar Q4 2026 | +27.8% | +7.5% | Lamb Weston raises FY2027 outlook as North America volume growth continues |
| MKC McCormick & Company, Incorporated | FY2026 Q3 · Calendar Q4 2026 | +13.9% | -4.9% | McCormick reports strong Q3 growth while U.S. volumes remain soft |
| COST Costco Wholesale Corporation | FY2026 Q4 · Calendar Q3 2026 | +3.2% | +2.9% | Costco’s growth broadens as warehouses and digital sales accelerate |
| GIS General Mills, Inc. | FY2027 Q1 · Calendar Q3 2026 | +4.6% | +1.0% | General Mills leans on mix, innovation and e-commerce amid pressure |
| KR The Kroger Co. | FY2026 Q2 · Calendar Q3 2026 | +2.8% | +2.7% | Kroger: Strong digital growth offsets softer sales outlook |
| CPB Campbell Soup Company | FY2026 Q4 · Calendar Q3 2026 | +1.1% | -7.0% | Campbell’s leans on savings and innovation amid pressured demand |
Latest beats and misses
Who reports nextBeat on EPS
- LWFY2027 Q1 · October 6, 2026+27.8% EPS+7.5% move
- RPMFY2027 Q1 · October 6, 2026+1.5% EPS+3.2% move
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
Get the CAG recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-12-05T00:03:44.862429+00:00
- Polygon adjusted daily market bars · 2026-10-07T19:00:43.469768+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-07T19:00:43.467081+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-07. For educational purposes only; not investment advice.